Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Management of Adults and Adolescents with Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Sickle Cell Disease Transition in Care
Release Date:
Partner: National Alliance of Sickle Cell Centers
Review Process: Expert Review Panel
Quality Improvement Rare Disease USA
Title
Grant Type
Focus Area
Country
Application Due Date
Efforts to Improve Quality of Migraine Medical Care
Release Date:
Partner: The Japanese Headache Society
Review Process: Expert Review Panel
Translation: Japanese (link)
Education Internal Medicine Japan
Pathological diagnosis and Immunohistochemistry biomarker assessments of Breast Cancer
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology Ghana
Evolving Treatment Options in First-line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)
Release Date:
Partner: Astellas
Review Process: Pfizer Internal
Education Oncology All
Investigator Sponsored Research for Understanding the Mechanisms and Formulating the Optimal Management of Hematological Toxicit
Release Date:
Partner: National Comprehensive Cancer Network
Review Process: Expert Review Panel
Research Oncology USA
Enhancing HCPs’ Preparedness: Maternal Immunization Knowledge Updates
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Interventional Research Studies with Elranatamab
Release Date:
Review Process: Pfizer Internal
Research Oncology All